Last update May 4, 2020
Likely Compatibility
We do not have alternatives for C11 H15 NO5.
Suggestions made at e-lactancia are done by APILAM team of health professionals, and are based on updated scientific publications. It is not intended to replace the relationship you have with your doctor but to compound it. The pharmaceutical industry contraindicates breastfeeding, mistakenly and without scientific reasons, in most of the drug data sheets.
Your contribution is essential for this service to continue to exist. We need the generosity of people like you who believe in the benefits of breastfeeding.
Thank you for helping to protect and promote breastfeeding.
C11 H15 NO5 is Methocarbamol in Molecular formula.
Is written in other languages:C11 H15 NO5 is also known as
Main tradenames from several countries containing C11 H15 NO5 in its composition:
Variable | Value | Unit |
---|---|---|
Oral Bioavail. | 100 | % |
Molecular weight | 241 | daltons |
Protein Binding | 46 - 50 | % |
VD | 0.48 | l/Kg |
pKa | 13.6 | - |
Tmax | 1.1 | hours |
T½ | 1.2 | hours |
Write us at elactancia.org@gmail.com
e-lactancia is a resource recommended by Academy of Breastfeeding Medicine - 2015 of United States of America
Would you like to recommend the use of e-lactancia? Write to us at corporate mail of APILAM
Is a centrally acting skeletal muscle relaxant with depressant effect on the central nervous system.
Oral administration 4 times a day.
At latest update no relevant data on this subject were found in connection with breastfeeding.
Despite excretion into breast milk is likely, the elimination rate is quite rapid.
Whenever possible use a minimal dose and let it to pass two hours until the next feed.
Watch for occurrence of symptoms like sedation and feeding refusal in the infant.
Avoid in infants younger than one month of age.